Clinical trials evaluating aceclidine-based ophthalmic solutions (such as VIZZ) for the treatment of presbyopia indicate that while the medication is generally well tolerated, patients can experience mild to moderate localized adverse reactions. The most frequently reported side effects include temporary eye irritation, transient dim or dark vision, headaches, and mild conjunctival or ocular hyperemia. Patients are typically advised to exercise caution regarding night driving or operating heavy machinery until any temporary visual adaptation effects subside.